This grant is for continuing support of the Integrated Islet Distribution Program, which helps provide human islets for diabetes research. It's specifically aimed at the Beckman Research Institute/City of Hope to renew their program. The goal is to keep supplying these important resources to researchers working on diabetes prevention and treatment.
Who it's for: This grant is specifically intended for the Beckman Research Institute/City of Hope to continue their work with the Integrated Islet Distribution Program. The program supports diabetes research by distributing human islets to scientists.
More details
Likely Disqualifiers
- Not being Beckman Research Institute/City of Hope
- Proposing a clinical trial
- Submitting after the deadline
- Not adhering to NIH peer-review standards
What You May Need
- Detailed project proposal
- Budget justification
- NIH peer-review compliance documents
- Organizational capability statement
- Letters of support from partners
- Proof of past performance in islet distribution
- NIH biosketches for key personnel
- Human subjects protection plan
- Data sharing plan
Cautions
- This is a single source grant for a specific organization.
- Clinical trials are not allowed under this grant.
- Strict adherence to NIH peer-review processes is required.
- Ensure all documents are submitted by the deadline.
Generated from official source details for readability
Eligibility
Eligible Applicant Types
Additional Criteria
The grant is specifically intended for the Beckman Research Institute/City of Hope to continue the Integrated Islet Distribution Program. This is a single source award, meaning that only this organization is eligible to apply. The program is part of the Special Diabetes Program, which supports innovative research on type 1 diabetes.
Overview
This grant is specifically intended for the Beckman Research Institute/City of Hope to continue their work with the Integrated Islet Distribution Program. The program supports diabetes research by distributing human islets to scientists.
Likely Disqualifiers
- Not being Beckman Research Institute/City of Hope
- Proposing a clinical trial
- Submitting after the deadline
- Not adhering to NIH peer-review standards
Use of Funds
Funds can be used to support the distribution of human islets for diabetes research, including partnerships with islet isolation facilities. The aim is to advance diabetes research and develop new therapies.
Total Program Funding
$3,300,000
Expected Awards
1
Cost Sharing
Not Required
Important Dates
- Posted
- May 20, 2026
- Deadline
- Sep 30, 2026(109 days)
- Archive Date
- Nov 29, 2026
Application Checklist
- Verify eligibility as Beckman Research Institute/City of Hope
- Prepare a detailed project proposal
- Compile budget and justification
- Gather letters of support
- Ensure compliance with NIH peer-review standards
- Submit application by September 30, 2026